Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 690692, 6 pages
http://dx.doi.org/10.1155/2015/690692
Review Article

Factors Influencing the Eicosanoids Synthesis In Vivo

1Department of Propaedeutic Oncology, Faculty of Health Sciences, Medical University of Gdańsk, Powstania Styczniowego 9b, 81-519 Gdynia, Poland
2Department of Surgical Oncology, Gdynia Oncology Center, PCK’s Maritime Hospital in Gdynia, Powstania Styczniowego 1, 81-519 Gdynia, Poland

Received 19 November 2014; Accepted 24 February 2015

Academic Editor: Beverly Muhlhausler

Copyright © 2015 Jarosław Szefel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Gibellini and T. K. Smith, “The Kennedy pathway-de novo synthesis of phosphatidylethanolamine and phosphatidylcholine,” IUBMB Life, vol. 62, no. 6, pp. 414–428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. D. Ha, B. A. Clarke, and W. J. Brown, “Regulation of the Golgi complex by phospholipid remodeling enzymes,” Biochimica et Biophysica Acta, vol. 1821, no. 8, pp. 1078–1088, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. L. McKimmie, L. Easter, and R. B. Weinberg, “Acyl chain length, saturation, and hydrophobicity modulate the efficiency of dietary fatty acid absorption in adult humans,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 305, no. 9, pp. G620–G627, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. N. Carley and A. M. Kleinfeld, “Flip-flop is the rate-limiting step for transport of free fatty acids across lipid vesicle membranes,” Biochemistry, vol. 48, no. 43, pp. 10437–10445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Siddiqi, A. Sheth, F. Patel, M. Barnes, and C. M. Mansbach II, “Intestinal caveolin-1 is important for dietary fatty acid absorption,” Biochimica et Biophysica Acta, vol. 1831, no. 8, pp. 1311–1321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Mu and C.-E. Høy, “The digestion of dietary triacylglycerols,” Progress in Lipid Research, vol. 43, no. 2, pp. 105–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Shim, C. L. Moulson, E. P. Newberry et al., “Fatty acid transport protein 4 is dispensable for intestinal lipid absorption in mice,” Journal of Lipid Research, vol. 50, no. 3, pp. 491–500, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Aguer, M. Foretz, L. Lantier et al., “Increased FAT/CD36 cycling and lipid accumulation in myotubes derived from obese type 2 diabetic patients,” PLoS ONE, vol. 6, no. 12, Article ID e28981, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Portolesi, B. C. Powell, and R. A. Gibson, “Competition between 24:5n-3 and ALA for Δ 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes,” Journal of Lipid Research, vol. 48, no. 7, pp. 1592–1598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Gibson, B. Muhlhausler, and M. Makrides, “Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2 years of life,” Maternal and Child Nutrition, vol. 7, supplement 2, pp. 17–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. P. Simopoulos, “Omega-3 fatty acids in health and disease and in growth and development,” The American Journal of Clinical Nutrition, vol. 54, no. 3, pp. 438–463, 1991. View at Google Scholar · View at Scopus
  12. S. K. Raatz, J. B. Redmon, N. Wimmergren, J. V. Donadio, and D. M. Bibus, “Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil,” Journal of the American Dietetic Association, vol. 109, no. 6, pp. 1076–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Kalvaria and J. E. Clain, “Diabetic diarrhoea and steatorrhoea. A case report and review of the literature,” South African Medical Journal, vol. 55, no. 14, pp. 562–564, 1979. View at Google Scholar · View at Scopus
  14. B. Walther, C. Clementsson, S. Vallgren, I. Ihse, and B. Akesson, “Fat malabsorption in patients before and after total gastrectomy, studied by the triolein breath test,” Scandinavian Journal of Gastroenterology, vol. 24, no. 3, pp. 309–314, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Moncada, A. G. Herman, E. A. Higgs, and J. R. Vane, “Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium,” Thrombosis Research, vol. 11, no. 3, pp. 323–344, 1977. View at Publisher · View at Google Scholar · View at Scopus
  16. A. J. Marcus, B. B. Weksler, and E. A. Jaffe, “Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells,” The Journal of Biological Chemistry, vol. 253, no. 20, pp. 7138–7141, 1978. View at Google Scholar · View at Scopus
  17. S. Bunting, R. Gryglewski, S. Moncada, and J. R. Vane, “Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation,” Prostaglandins, vol. 12, no. 6, pp. 897–913, 1976. View at Google Scholar · View at Scopus
  18. J. Nowak and G. A. FitzGerald, “Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man,” Journal of Clinical Investigation, vol. 83, no. 2, pp. 380–385, 1989. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. McGee and F. A. Fitzpatrick, “Erythrocyte-neutrophil interactions: Formation of leukotriene B4 by transcellular biosynthesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 5, pp. 1349–1353, 1986. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Maugeri, V. Evangelista, A. Celardo et al., “Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis,” Thrombosis and Haemostasis, vol. 72, no. 3, pp. 450–456, 1994. View at Google Scholar · View at Scopus
  21. E. Peranzoni, S. Zilio, I. Marigo et al., “Myeloid-derived suppressor cell heterogeneity and subset definition,” Current Opinion in Immunology, vol. 22, no. 2, pp. 238–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Ribechini, V. Greifenberg, S. Sandwick, and M. B. Lutz, “Subsets, expansion and activation of myeloid-derived suppressor cells,” Medical Microbiology and Immunology, vol. 199, no. 3, pp. 273–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Raber, A. C. Ochoa, and P. C. Rodríguez, “Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives,” Immunological Investigations, vol. 41, no. 6-7, pp. 614–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. J. Popovic, H. J. Zeh III, and J. B. Ochoa, “Arginine and immunity,” Journal of Nutrition, vol. 137, supplement 2, no. 6, pp. 1681S–1686S, 2007. View at Google Scholar · View at Scopus
  25. M. Munder, H. Schneider, C. Luckner et al., “Suppression of T-cell functions by human granulocyte arginase,” Blood, vol. 108, no. 5, pp. 1627–1634, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. P. C. Rodriguez, A. H. Zea, J. DeSalvo et al., “L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes,” Journal of Immunology, vol. 171, no. 3, pp. 1232–1239, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. S. Yarandi, V. M. Zhao, G. Hebbar, and T. R. Ziegler, “Amino acid composition in parenteral nutrition: what is the evidence?” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14, no. 1, pp. 75–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Yaqoob and P. C. Calder, “Cytokine production by human peripheral blood mononuclear cells: differential sensitivity to glutamine availability,” Cytokine, vol. 10, no. 10, pp. 790–794, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Murphy and P. Newsholme, “Macrophage-mediated lysis of a beta-cell line, tumour necrosis factor-alpha release from bacillus Calmette-Guerin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism,” Clinical Science, vol. 96, no. 1, pp. 89–97, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Sfar, F. Laporte, H. Braham, A. Jawed, S. Amor, and A. Kerkeni, “Influence of dietary habits, age and gender on plasma fatty acids levels in a population of healthy Tunisian subjects,” Experimental Gerontology, vol. 45, no. 9, pp. 719–725, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Kawashimia, N. Uy-Yu, and H. Kozuka, “Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol,” Biochemical Journal, vol. 263, no. 3, pp. 897–904, 1989. View at Google Scholar · View at Scopus
  32. D. F. Horrobin, “Loss of delta-6-desaturase activity as a key factor in aging,” Medical Hypotheses, vol. 7, no. 9, pp. 1211–1220, 1981. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Hrelia, A. Bordoni, M. Celadon, E. Turchetto, P. L. Biagi, and C. A. Rossi, “Age-related changes in linoleate and α-linolenate desaturation by rat liver microsomes,” Biochemical and Biophysical Research Communications, vol. 163, no. 1, pp. 348–355, 1989. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Hrelia, M. Celadon, C. A. Rossi, P. L. Biagi, and A. Bordoni, “Delta-6-desaturation of linoleic and α-linolenic acids in aged rats: a kinetic analysis,” Biochemistry International, vol. 22, no. 4, pp. 659–667, 1990. View at Publisher · View at Google Scholar · View at Scopus
  35. D. E. Barre, “The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes—a mini-review,” Journal of Oleo Science, vol. 56, no. 7, pp. 319–325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Kröger and M. B. Schulze, “Recent insights into the relation of Δ5 desaturase and Δ6 desaturase activity to the development of type 2 diabetes,” Current Opinion in Lipidology, vol. 23, no. 1, pp. 4–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Eder and M. Kirchgessner, “Activities of liver microsomal fatty acid desaturases in zinc-deficient rats force-fed diets with a coconut oil/safflower oil mixture of linseed oil,” Biological Trace Element Research, vol. 48, no. 3, pp. 215–229, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Eder and M. Kirchgessner, “Zinc deficiency and the desaturation of linoleic acid in rats force-fed fat-free diets,” Biological Trace Element Research, vol. 54, no. 2, pp. 173–181, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Bordoni, S. Hrelia, A. Lorenzini et al., “Dual influence of aging and vitamin B6 deficiency on delta-6-desaturation of essential fatty acids in rat liver microsomes,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 58, no. 6, pp. 417–420, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Tsuge, N. Hotta, and T. Hayakawa, “Effects of vitamin B-6 on (n-3) polyunsaturated fatty acid metabolism,” Journal of Nutrition, vol. 130, no. 25, supplement, pp. 333S–334S, 2000. View at Google Scholar · View at Scopus
  41. R. Zolfaghari, C. J. Cifelli, M. D. Banta, and A. C. Ross, “Fatty acid Δ5-Desaturase mRNA is regulated by dietary vitamin A and exogenous retinoic acid in liver of adult rats,” Archives of Biochemistry and Biophysics, vol. 391, no. 1, pp. 8–15, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. U. N. Das, “Fetal alcohol syndrome and essential fatty acids,” PLoS Medicine, vol. 3, no. 5, article e247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. R. N. Puri, “Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms,” The International Journal of Biochemistry & Cell Biology, vol. 30, no. 10, pp. 1107–1122, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. S. A.-V. Leyen, M. F. Romero, M. C. Khosla, and J. G. Douglas, “Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7),” Kidney International, vol. 44, no. 5, pp. 932–936, 1993. View at Publisher · View at Google Scholar · View at Scopus
  45. R. T. Abraham, M. M. McKinney, C. Forray, G. D. Shipley, and B. S. Handwerger, “Stimulation of arachidonic acid release and eicosanoid biosynthesis in an interleukin 2-dependent T cell line,” Journal of Immunopharmacology, vol. 8, no. 2, pp. 165–204, 1986. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Caiazza, B. J. Harvey, and W. Thomas, “Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth,” Molecular Endocrinology, vol. 24, no. 5, pp. 953–968, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Oleksowicz, Y. Liu, R. B. Bracken et al., “Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer,” Prostate, vol. 72, no. 10, pp. 1140–1149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Hernandez, R. Martin, M. D. Garcia-Cubillas, P. Maeso-Hernandez, and M. L. Nieto, “Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: another inflammation-cancer link,” Neuro-Oncology, vol. 12, no. 10, pp. 1014–1023, 2010. View at Publisher · View at Google Scholar
  49. F. F. Davidson, E. A. Dennis, M. Powell, and J. R. Glenney Jr., “Inhibition of phospholipase A2 by ‘lipocortins’ and calpactins. An effect of binding to substrate phospholipids,” Journal of Biological Chemistry, vol. 262, no. 4, pp. 1698–1705, 1987. View at Google Scholar · View at Scopus
  50. Y. Li, H. Yamada, Y. Kita et al., “Roles of ERK and cPLA2 in the angiotensin II-mediated biphasic regulation of Na+-HCO3 transport,” Journal of the American Society of Nephrology, vol. 19, no. 2, pp. 252–259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Holinstat, O. Boutaud, P. L. Apopa et al., “Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 2, pp. 435–442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. R. M. Kramer, E. F. Roberts, J. V. Manetta, P. A. Hyslop, and J. A. Jakubowski, “Thrombin-induced phosphorylation and activation of Ca2+-sensitive cytosolic phospholipase A2 in human platelets,” Journal of Biological Chemistry, vol. 268, no. 35, pp. 26796–26804, 1993. View at Google Scholar · View at Scopus
  53. W. E. M. Lands, “Stories about acyl chains,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1483, no. 1, pp. 1–14, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Shindou and T. Shimizu, “Acyl-CoA:lysophospholipid acyltransferases,” Journal of Biological Chemistry, vol. 284, no. 1, pp. 1–5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. E. Soupene and F. A. Kuypers, “Mammalian long-chain acyl-CoA synthetases,” Experimental Biology and Medicine, vol. 233, no. 5, pp. 507–521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Arduini, V. Tyurin, Y. Tyuruna et al., “Acyl-trafficking in membrane phospholipid fatty acid turnover: the transfer of fatty acid from the acyl-L-carnitine pool to membrane phospholipids in intact human erythrocytes,” Biochemical and Biophysical Research Communications, vol. 187, no. 1, pp. 353–358, 1992. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Arduini, G. Mancinelli, and R. R. Ramsay, “Palmitoyl-L-carnitine, a metabolic intermediate of the fatty acid incorporation pathway in erythrocyte membrane phospholipids,” Biochemical and Biophysical Research Communications, vol. 173, no. 1, pp. 212–217, 1990. View at Publisher · View at Google Scholar · View at Scopus
  58. C. N. Serhan, “Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution,” Prostaglandins and Other Lipid Mediators, vol. 68-69, pp. 433–455, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Fiorucci, O. M. De Lima Jr., A. Mencarelli et al., “Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage,” Gastroenterology, vol. 123, no. 5, pp. 1598–1606, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. J. L. Wallace, S. R. Zamuner, W. McKnight et al., “Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 286, no. 1, pp. G76–G81, 2004. View at Google Scholar · View at Scopus
  61. M. Arita, T. Ohira, Y. P. Sun, S. Elangovan, N. Chiang, and C. N. Serhan, “Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation,” Journal of Immunology, vol. 178, no. 6, pp. 3912–3917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. S. F. Oh, P. S. Pillai, A. Recchiuti, R. Yang, and C. N. Serhan, “Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation,” Journal of Clinical Investigation, vol. 121, no. 2, pp. 569–581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. Y.-P. Sun, S. F. Oh, J. Uddin et al., “Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation,” Journal of Biological Chemistry, vol. 282, no. 13, pp. 9323–9334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Hong, K. Gronert, P. R. Devchand, R.-L. Moussignac, and C. N. Serhan, “Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation,” The Journal of Biological Chemistry, vol. 278, no. 17, pp. 14677–14687, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. H. R. O'Neal, T. Koyama, E. A. S. Koehler et al., “Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome,” Critical Care Medicine, vol. 39, no. 6, pp. 1343–1350, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Spite and C. N. Serhan, “Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins,” Circulation Research, vol. 107, no. 10, pp. 1170–1184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. J. N. Fullerton, A. J. O'Brien, and D. W. Gilroy, “Lipid mediators in immune dysfunction after severe inflammation,” Trends in Immunology, vol. 35, no. 1, pp. 12–21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Hammarberg, P. Provost, B. Persson, and O. Rådmark, “The N-terminal domain of 5-lipoxygenase binds calcium and mediates calcium stimulation of enzyme activity,” The Journal of Biological Chemistry, vol. 275, no. 49, pp. 38787–38793, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. C. N. Serhan, S. Krishnamoorthy, A. Recchiuti, and N. Chiang, “Novel anti-inflammatory—pro-resolving mediators and their receptors,” Current Topics in Medicinal Chemistry, vol. 11, no. 6, pp. 629–647, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Pergola, A. Rogge, G. Dodt et al., “Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes,” The FASEB Journal, vol. 25, no. 10, pp. 3377–3387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Pergola, G. Dodt, A. Rossi et al., “ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19881–19886, 2008. View at Publisher · View at Google Scholar · View at Scopus